Home
Journal Information
About
Aims and Scope
Editorial Board
Editor in Chief
Open Access
Editorial Office
Editorial Policies
Journal Issues
Current Issue
In Press
All Issues
Contact Us
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
2008-5117
eISSN
:
2008-6830
Submit Your Paper
Instructions for Authors
Instructions for Reviewers
Editor in Chief
Editorial Board
Editorial Policies
English Editing Service
Indexing and Abstracting
Archive
Collaborator of
J Cardiovasc Thorac Res
. 2023;15(3): 138-144. doi:
10.34172/jcvtr.2023.31724
PMID:
38028722
PMCID:
PMC10590461
Original Article
Sevoflurane-mediated modulation of oxidative myocardial injury
Siavash Sedghi
1
,
2
, Wiam Z. Khadra
1
,
2
, Leili Pourafkari
1
,
3
, Paul R. Knight
1
, Faraz A. Alderson
4
, Nader D. Nader
1
,
2
*
Cited by CrossRef:
1- Shao Y, Gu Q, Yuan Y, Wang L, Yu T. The Preconditioning with Sevoflurane Alleviates Hypoxia-Reoxygenation-Induced Myocardial Cell Injury by Regulating the lncRNA LINC00265/miR-370-3p Axis.
Cardiovasc Toxicol
. 2025;25(5):778
[Crossref]
2- Lin J, Li X, Yang Y, Ge Z, Liu D, Yang C, Zhang L, Xia Z, Xia Z. Protective effects of sevoflurane conditioning against myocardial ischemia-reperfusion injury: a review of evidence from animal and clinical studies.
Anesthesiol Perioper Sci
. 2025;3(1)
[Crossref]
3- Wang L, Zhu C, Shao Y, Chen R, Liang H. Sevoflurane reduces cardiomyocyte injury in a hypoxia/reoxygenation model of cardiomyocytes through the linc01278/miR-134-5pt regulatory axis.
BMC Pharmacol Toxicol
. 2025;26(1)
[Crossref]
Platinum Open Access
This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.
Indexing Info